Preeclampsia: The endothelium, circulating factor(s) and vascular endothelial growth factor

Journal of the Society for Gynecologic Investigation

Volumn 6, Issue 1, 1999, Pages 3-10

  Hayman, Richard ^a   Brockelsby, Jeremy ^a   Kenny, Louise ^a   Baker, Philip ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Circulating factor; Endothelium; Factor; Myography; Preeclampsia; Vascular endothelial growth

Indexed keywords

FIBRONECTIN; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTACYCLIN; TISSUE PLASMINOGEN ACTIVATOR; VASCULOTROPIN; VON WILLEBRAND FACTOR;

BLOOD CLOTTING; BLOOD VESSEL PERMEABILITY; ENDOTHELIUM CELL; HUMAN; MYOGRAPHY; MYOMETRIUM; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM;

ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LYMPHOKINES; PRE-ECLAMPSIA; PREGNANCY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032935619     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(98)00044-6     Document Type: Review

References (70)

1. Ferris T.F. Pregnancy, preeclampsia, and the endothelial cell. N Engl J Med. 325:1991;1439-1442.
2. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., McLaughlin M.K. Preeclampsia an endothelial cell disorder . Am J Obstet Gynecol. 161:1989;1200-1204.
3. Spargo B., McCartney C.P., Winemiller R. Glomerular capillary endotheliosis in toxemia of pregnancy. Arch Pathol. 68:1959;593-599.
4. Campbell D.M., Campbell A.J. Evans blue disappearance rate in normal and preeclamptic pregnancy. Clin Exp Hypertens. 2:1983;163-169.
5. Friedman S.A., Taylor R.N., Roberts J.M. Pathophysiology of preeclampsia. Clin Perinatol. 18:1991;661-682.
6. Taylor R.N., Varma M., Teng N.N.H., Roberts J.M. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab. 71:1990;1675-1677.
7. Mastrogiannis D.S., O'Brien W.F., Krammer J., Benoit R. Potential role of endothelins in normal and hypertensive pregnancies. Am J Obstet Gynecol. 165:1991;1711-1716.
8. MacCumber M.W., Ross C.A., Glaser B.M., Snyder S.H. Endothelin visualization of mRNAs by in situ hybridization provides evidence for local action . Proc Nat Acad Sci USA. 86:1989;7285-7289.
9. Yoshimoto S., Ishizaki Y., Kurihara H., et al. Cerebral microvessel endothelium is producing endothelin. Brain Res. 508:1990;283-285.
10. Roberts J.M., Redman C.W.G. Preeclampsia more than pregnancy induced hypertension . Lancet. 341:1993;1447-1451.
11. Davies J.A., Prentice C.R.M. Coagulation changes in pregnancy induced hypertension and growth retardation. Greer I.A., Turpie A.G.G., Forbes C.D. Haemostasis and thrombosis in obstetrics and gynaecology. 1992;143-162 Chapman and Hall, London.
12. Baker P.N. The prediction of preeclampsia. Curr Obstet Gynaecol. 3:1993;69-74.
13. Grant N.F., Daley G.L., Chand S., Whalley P.J., McDonald P.C. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 52:1973;2682-2689.
14. McCarthy A.L., Woolfson R.G., Raju S.K., Poston L. Abnormal endothelial cell function of resistance arteries in women with preeclampsia. Am J Obstet Gynecol. 168:1993;1323-1330.
15. Knock G.A., Poston L. Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal and preeclampsia. Am J Obstet Gynecol. 175:1996;1668-1674.
16. Ashworth J.R., Warren A.Y., Baker P.N., Johnson I.R. Loss of endothelium-dependent relaxation in myometrial resistance arteries in preeclampsia. Br J Obstet Gynaecol. 104:1997;1152-1158.
17. Furchgott R.F., Zawadski J.V. The obligatory role of endothelial cells in the relaxation of smooth muscle by acetylcholine. Nature. 288:1980;373-376.
18. Palmer R.M.J., Ferrige A.G., Maconda S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
19. Ignarro L.J., Buga G.M., Woods K.S., Byrns R.E., Chaudhari G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 84:1987;9265-9269.
20. Kuriyama H., Suzuki H. The effects of acetylcholine on the membrane and contractile properties of smooth muscle cells of the rabbit superior mesenteric artery. Br J Pharmacol. 64:1978;493-501.
21. Bolton T.B., Lang R.J., Takewaki T. Mechanism of action of noradrenaline and carbachol on smooth muscle guinea-pig anterior mesenteric artery. J Physiol. 351:1984;549-572.
22. Nakashima M., Mombouli J.V., Taylor A., Vanhoutte P.M. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest. 23:1993;747-756.
23. Randall M.D., Alexander S.P.H., Bennett T.E., et al. An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem Biophys Res Commun. 229:1996;114-120.
24. Ashworth JR, Baker PN, Warren AY, Johnson IR. The mechanisms of endothelium-dependent relaxation in myometrial resistance vessels and their alterations in preeclampsia. Hypertens Pregnancy 1998; in press.
25. Page E.W. The relation between hydatidiform moles, relative ischaemia of the gravid uterus, and placental origin of preeclampsia. Am J Obst Gynecol. 37:1939;291-293.
26. Rodgers G.M., Taylor R.N., Roberts J.M. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol. 159:1988;908-914.
27. Tsukimori K., Maeda H., Shingu M., Koyanagi T., Nobunaga M., Nakano H. The possible role of endothelial cells in hypertensive disorders during pregnancy. Obstet Gynecol. 80:1992;229-233.
28. Lorentzen B., Endersen T., Hovig E., et al. Sera from preeclamptic women increases the content of triglycerides and reduces the release of prostacyclin in cultured endothelial cells. Thromb Res. 63:1991;363-372.
29. Baker P.N., Davige S.T., Roberts J.M. Plasma from women with preeclampsia increases endothelial cell nitric oxide production. Hypertension. 26:1995;244-248.
30. de Groot C.J., Davidge S.T., Friedman S.A., McLaughlin M.K., Roberts J.M., Taylor R.N. Plasma from preeclamptic women increases human endothelial cell prostacyclin production without changes in cellular enzyme activity or mass. Am J Obstet Gynecol. 172:1995;976-985.
31. Hayman R, Sattar N, Warren AY, Greer I, Johnson I, Baker PN. A relationship between myometrial resistance artery behavior and circulating lipid composition. Am J Obstet Gynecol 1998; in press.
32. Ashworth J.R., Warren A.Y., Johnson I.R., Baker P.N. Plasma from preeclamptic women and functional change in myometrial resistance arteries. Br J Obstet Gynaecol. 4:1998;459-461.
33. Roberts J.M., Taylor R.N., Goldfien A. Clinical and biochemical evidence of endothelial dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens. 4:1991;700-708.
34. Roberts J.M., Edep M.E., Goldfein A., Taylor R.N. Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro. Am J Reprod Immunol. 27:1992;101-108.
35. Taylor R.N., Musci T.J., Rodgers G.M., Roberts J.M. Preeclamptic sera stimulate increased platelet-derived growth factor mRNA and protein expression by cultured human endothelial cells. Am J Reprod Immunol. 25:1991;105-108.
36. Haller H., Hempel A., Homuth V., et al. Endothelial-cell permeability and protein kinase C in preeclampsia. Lancet. 351:1998;945-949.
37. Myatt L. Ecosanoids and blood pressure regulation. Sharp F., Symonds E.M. Hypertension in pregnancy proceedings of the 16th Study Group of the RCOG . 1987;Perinatology Press, New York.
38. Brown M.A., Tibben E., Zammit V.C., Cario G.M., Carlton M.A. Nitric oxide excretion in normal and hypertensive pregnancies. Hypertens Pregnancy. 14:1995;319-326.
39. Wellings R.P., Brockelsby J.C., Baker P.N. Activation of endothelial cells by plasma from women with preeclampsia differential effects of four endothelial cell types . J Soc Gynecol Invest. 5:1998;31-37.
40. Baker P.N., Davidge S.T., Barankiewicz J., Roberts J.M. Plasma of preeclamptic women initially stimulates then inhibits endothelial prostacyclin production. Hypertension. 27:1996;56-61.
41. Davidge S.T., Baker P.N., McLaughlin M.M., Roberts J.M. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res. 77:1995;274-283.
42. Fox P.L., DiCorleto P.E. Regulation of production of a platelet derived growth factor-like protein by cultured bovine aortic endothelial cells. J Cell Physiol. 121:1984;298-308.
43. Sattar N., Bendomir A., Berry C., Shepherd J., Greer I.A., Packard C.J. Lipoprotein subfractions in preeclampsia pathogenic parallels to atherosclerosis . Obstet Gynecol. 89:1997;403-408.
44. Hayman R., Brockelsby J., Warren A., Ashworth J., Johnson I., Baker P. Evidence for a circulating factor in preeclampsia. A role for vascular endothelial growth factor? Br J Obstet Gynaecol. 105:1998;39-40.
45. Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 219:1983;983-985.
46. Miles A.A., Miles E.M. Vascular reactions to histamine, histamine liberator and leukotaxine in the skin of guinea-pigs. J Physiol. 118:1952;228-257.
47. Connolly D.T., Heuvelman D.M., Nelson R., et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 84:1989;1470-1478.
48. Ferrara N., Houck K., Jakeman L., Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 13:1992;18-32.
49. Keck P.J., Hauser S.D., Krivi G., et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 246:1989;1309-1312.
50. Terman B.I., Dougher-Vermazen M., Carrion M.E., et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun. 187:1992;1579-1586.
51. Vaisman N., Gospodarowicz D., Neufeld G. Characterization of the receptors for vascular endothelial growth factor. J Biol Chem. 194:1990;61-66.
52. Murohara T., Horowitz J.R., Silver M., et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation. 97:1998;97-107.
53. Baker P.N., Krasnow J., Roberts J.M., Yeo K.T. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol. 86:1995;815-821.
54. Sharkey A.M., Cooper J.C., Balmforth J.R., et al. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by preeclampsia. Eur J Clin Invest. 26:1996;1182-1185.
55. Brockelsby J.C., Anthony F., Johnson I.R.J., Wheeler T., Baker P.N. Increased serum vascular endothelial growth factor concentrations in pre-eclampsia. Hypertens Pregnancy. 17:1998;283-290.
56. Wheeler T., Brockelsby J., Wellings R.P., Anthony F., Evans P., Baker P.N. Serum levels of vascular endothelial growth factor are raised in preeclamptic versus normotensive pregnant women. J Soc Clin Invest. 4:1997;194A.
57. Lyall F., Greer I.A., Boswell F., Fleming R. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in preeclampsia. Br J Obstet Gynaecol. 104:1997;223-228.
58. Anthony F.W., Evans P.W., Wheeler T., Wood P.J. Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann Clin Biochem. 34:1997;276-280.
59. Banks R.E., Forbes M.A., Searles J., et al. Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1. Mol Hum Reprod. 4:1998;377-386.
60. Jackson M.R., Carney E.W., Lye S.J., Knox Ritchie J.W. Localisation of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation. Placenta. 15:1994;341-353.
61. Taylor C.M., Stevens H., Anthony F.W., Wheeler T. Influence of hypoxia on vascular endothelial growth factor and chorionic gonadotrophin production in the trophoblast-derived cell lines JEG, JAr and BeWo . Placenta. 18:1997;451-458.
62. Redman C.W.G., Beilin L.J., Bonnar J. Renal function in preeclampsia. J Clin Pathol. 10:1976;91-94.
63. Tsurumi Y., Murohara T., Krainski K., et al. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nature Med. 3:1997;879-886.
64. Wu H.M., Huang Q., Yuan Y., Granger H.J. VEGF induces NO-dependent hyperpermeability in coronary venules. Am J Physiol. 271:1996;H2735-H2739.
65. Ni Y., May V., Braas K., Osol G. Pregnancy augments uteroplacental vascular endothelial growth factor gene expression and vasodilator effects. Am J Physiol. 273:1997;H938-H944.
66. Ahmed A., Dunk C., Kniss D., Wilkes M. Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab Invest. 76:1997;779-791.
67. Brockelsby J.C., Wellings R.P., Baker P.N. Vascular Endothelial growth factor (VEGF) alters endothelial cell function. J Clin Sci. 93:1997;8.
68. Davidge S.T., Signorella A.P., Hubel C.A., Lykins D.L., Roberts J.M. Distinct factors in plasma of preeclamptic women increase endothelial nitric oxide or prostacyclin. Hypertension. 28:1996;758-764.
69. Brockelsby J., Hayman R., Warren A., Johnson I., Baker P. Preeclampsia a role for vascular endothelial growth factor . J Soc Gynecol Invest. 5:1998;67A.
70. Grant J.M. Confusion with Doppler, certainty with salt, and more basic science needed in preeclampsia. Br J Obstet Gynaecol. 105:1998;v.